MCCAMISH MARK ANTHONY received a stock award from AVADEL PHARMACEUTICALS PLC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/31/2025ACC: 0001104659-25-072695
Director
Since Dec 2019
+22K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
22K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+11K
Price / share
—
Trade value
—
% of position
100.0%
7/29/2025
11K→22K
Total
Net shares
+11K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 7/29/2025 | A · Award | +11K | — | — | 100.0% | 11K | 22K |
| Total | +11K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Ordinary Shares
11K shares
Shares
+11K
Strike price
10.83
Held after
11K
Exercisable
—
7/29/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Ordinary Shares11K shares | 7/29/2025 | A · Award | +11K | 10.83 | — | 11K |
Non-Derivative Holdings (Post-Transaction)1
Ordinary Shares
IndirectShares owned67.03K
Total
67.03K indirect67.03K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 67.03K | Indirect |
| Total | 67.03K | 67.03K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported